Skip to content
Clinical Trials – home

Epilepsy Diagnostics

Clinical trials for Epilepsy

Recruiting trials first

See all 18 trials →
Quick filters

18 clinical trials in this condition

Epilepsy

Recruiting

Phase 2 Study Evaluating OV329 on Photo‑Induced EEG Response in Adults with Epilepsy

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years

Epilepsy

Recruiting

[18F]CPFPX PET in Patients With Drug-Resistant Epilepsy and Healthy Subjects

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · Healthy volunteers
  • Substances:[18F]CPFPX
  • Sponsor:Hospices Civils De Lyon

Study on the Safety and Effectiveness of Sirolimus and Vigabatrin for Preventing Symptoms in Infants with Tuberous Sclerosis Complex

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Sirolimus
  • Sponsor:Instytut Pomnik Centrum Zdrowia Dziecka

Study on the Effectiveness and Safety of Sirolimus for Patients with Drug-Resistant Epilepsy Linked to Tuberous Sclerosis Complex

Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Sirolimus
  • Sponsor:Instytut Pomnik Centrum Zdrowia Dziecka
See all 18 trials →filters applied: condition = Epilepsy

In short

Diagnosing epilepsy involves careful evaluation of seizures and brain activity to determine the best path forward for each person. Understanding how doctors identify this condition can help you feel more prepared and informed about the process, whether for yourself or someone you care about.

Key points

  • Epilepsy is typically diagnosed after two or more unprovoked seizures, not just one single episode.
  • The EEG test measures brain electrical activity and is the cornerstone of epilepsy diagnosis, often detecting abnormalities even between seizures.
  • Brain imaging with MRI or CT scans can reveal physical causes of seizures like tumors, scarring, or developmental abnormalities.
  • Bringing someone who witnessed your seizure to medical appointments provides crucial information that helps doctors make an accurate diagnosis.
  • Blood tests and ECGs help rule out other medical conditions that could be causing seizure-like symptoms.
  • Up to 70% of people with epilepsy can become seizure-free with proper diagnosis and treatment.
  • Clinical trials for epilepsy require more extensive diagnostic testing to ensure participants meet specific criteria and to monitor their progress closely.
  • The risk of premature death in people with epilepsy is up to three times higher than the general population, but good seizure control significantly reduces this risk.

Introduction: Who Should Undergo Diagnostics

If you or someone close to you has experienced a seizure, seeking medical evaluation is an important first step. However, having one seizure does not automatically mean a person has epilepsy. According to health experts, up to 10% of people worldwide will have a single seizure at some point in their lives. Epilepsy is typically diagnosed only when someone has experienced two or more unprovoked seizures, meaning seizures that occur without an obvious trigger like high fever, low blood sugar, or head injury.

You should seek urgent medical attention if you think you or your child may have had a seizure for the first time, especially if the episode was unexplained. Even if you did not go to the hospital immediately after the event, it is important to contact your doctor or seek an urgent appointment. Similarly, if someone who has been seizure-free for a long time suddenly experiences another episode, this warrants immediate medical review.

People of any age can develop epilepsy, though symptoms often begin in young children or in people over the age of 50. The decision to undergo diagnostic testing typically follows an initial seizure event or repeated episodes that cannot be explained by other medical conditions. Diagnostic evaluation becomes especially important when seizures interfere with daily activities, occur frequently, or do not respond to initial treatments.

Diagnostic Methods: How Epilepsy Is Identified

When you visit a specialist after experiencing a seizure, the doctor will conduct a thorough evaluation to determine whether you have epilepsy and, if so, what type. This process involves gathering detailed information about your medical history, performing physical examinations, and conducting various tests. The goal is not only to confirm epilepsy but also to identify what might be causing the seizures and to rule out other conditions that could produce similar symptoms.

Clinical History and Physical Examination

The diagnostic process begins with a detailed conversation. Your doctor will ask about what happened before, during, and after the seizure. Because many people do not remember their seizures clearly, it can be very helpful to bring someone who witnessed the episode to your appointment. That person can describe what they saw, which provides valuable clues about the type of seizure.

Your doctor will want to know about any family history of epilepsy or seizures, previous head injuries, infections affecting the brain, strokes, or other neurological conditions. They will also ask about potential triggers—factors that might provoke seizures—such as lack of sleep, stress, flashing lights, alcohol use, or missed medications. Understanding the full picture of your health helps the medical team narrow down possible causes and decide which tests are most appropriate.

Electroencephalogram (EEG)

One of the most important diagnostic tools for epilepsy is the electroencephalogram, commonly called an EEG. This test measures the electrical activity in your brain. During an EEG, small metal discs called electrodes are placed on your scalp. These electrodes detect the tiny electrical signals that brain cells use to communicate with each other. The test is painless and non-invasive.

In people with epilepsy, the EEG often shows abnormal patterns of electrical activity, even between seizures. These patterns help doctors identify the type of epilepsy you have and can indicate which areas of the brain are affected. Sometimes, if the first EEG does not show clear results, your doctor may recommend longer monitoring, such as a 24-hour or even multi-day EEG recording. This extended monitoring increases the chance of capturing abnormal brain activity.

Brain Imaging: MRI and CT Scans

Imaging tests allow doctors to look at the structure of your brain to see if there is any physical cause for the seizures. The two most common imaging methods are magnetic resonance imaging (MRI) and computed tomography (CT) scans.

An MRI uses powerful magnets and radio waves to create detailed pictures of the brain. It can reveal problems such as brain tumors, areas of scarring, abnormal blood vessels, or developmental abnormalities that might be triggering seizures. MRI scans are especially useful because they provide very clear images of soft tissues in the brain.

A CT scan uses X-rays to create cross-sectional images of the brain. While not as detailed as an MRI, a CT scan is faster and may be used in emergency situations to quickly rule out serious problems like bleeding or large tumors. Both tests are painless, though they require you to lie still inside a large machine for a period of time.

Blood Tests

Blood tests are a routine part of the diagnostic workup for epilepsy. These tests can help identify underlying medical conditions that might be causing or contributing to seizures. For example, blood tests can detect imbalances in electrolytes, low blood sugar, infections, liver or kidney problems, or genetic conditions.

In some cases, doctors may order genetic testing to look for inherited forms of epilepsy. Genetic factors play a role in certain types of epilepsy, particularly those that begin in childhood. Identifying a genetic cause can help guide treatment decisions and provide information about the likelihood of other family members being affected.

Electrocardiogram (ECG)

Sometimes, episodes that look like seizures are actually caused by heart problems. An electrocardiogram, or ECG, records the electrical activity of your heart. This test helps doctors rule out cardiac conditions, such as irregular heart rhythms, that can cause fainting or blackouts that might be mistaken for seizures.

Additional Specialized Tests

In more complex cases, doctors may use additional tests to gather more information. For example, if the location of the seizure activity is unclear, or if surgery is being considered as a treatment option, more advanced imaging or monitoring techniques may be needed. These might include video-EEG monitoring, where the patient is recorded on video while their brain activity is monitored continuously, allowing doctors to see exactly what happens during a seizure and correlate it with brain wave changes.

Distinguishing Epilepsy from Other Conditions

Part of the diagnostic process involves making sure that what appears to be epilepsy is not actually something else. Certain conditions can mimic epileptic seizures. For instance, fainting spells, panic attacks, migraines, sleep disorders, or psychogenic non-epileptic seizures (episodes that resemble seizures but are not caused by abnormal electrical activity in the brain) can all be confused with epilepsy. Careful evaluation, including EEG monitoring and sometimes psychological assessment, helps doctors make the correct diagnosis.

Diagnostics for Clinical Trial Qualification

When people with epilepsy are considered for participation in clinical trials, they typically undergo a more rigorous and detailed set of diagnostic tests. Clinical trials are research studies that test new treatments, medications, devices, or other interventions to see if they are safe and effective. Because these studies need to ensure that all participants meet very specific criteria, the diagnostic requirements are often more extensive than those used in routine clinical practice.

The exact tests required depend on the specific clinical trial and its goals. However, most epilepsy clinical trials share some common diagnostic requirements to ensure that participants truly have epilepsy, to classify their seizure type accurately, and to assess their overall health.

Confirming the Diagnosis

Clinical trials usually require clear, documented evidence that a participant has epilepsy. This typically means having medical records that show at least two unprovoked seizures, along with supporting test results such as EEG abnormalities. Some trials may accept participants only if they have a certain type of epilepsy or if their seizures originate in a specific part of the brain.

Participants may need to undergo a new EEG or MRI scan as part of the screening process, even if they have had these tests before. This ensures that the most current and accurate information is available to the research team.

Seizure Frequency and Type

Many clinical trials are designed for people whose seizures are not well controlled by medication—a condition known as drug-resistant epilepsy or refractory epilepsy. To qualify, participants often need to demonstrate that they have experienced a minimum number of seizures over a certain period, such as at least four seizures per month for three consecutive months. Keeping a detailed seizure diary is often required to document the frequency, duration, and characteristics of seizures.

The type of seizure also matters. Some trials focus on specific seizure types, such as tonic-clonic seizures (where the body stiffens and jerks) or focal seizures (which start in one area of the brain). Accurate classification of seizure type, usually confirmed by video-EEG monitoring, is essential for determining eligibility.

Baseline Health Assessments

Before joining a clinical trial, participants undergo comprehensive health assessments to ensure they are healthy enough to participate and to establish baseline measurements. These assessments typically include blood tests to check liver and kidney function, blood cell counts, and electrolyte levels. These tests help identify any underlying health issues that could affect participation or that might be impacted by the experimental treatment.

Heart function is also commonly assessed using an ECG, and sometimes additional cardiac monitoring is required if the trial involves a treatment that could potentially affect the heart. Pregnancy tests are required for women of childbearing age, as many epilepsy medications and experimental treatments can harm a developing fetus.

Neuropsychological Testing

Some epilepsy clinical trials include neuropsychological testing to assess cognitive function, memory, mood, and quality of life. These tests provide a baseline against which any changes during the trial can be measured. This is particularly important for trials testing new medications, as some epilepsy drugs can affect thinking, mood, or behavior.

Medication History

Participants in epilepsy trials are usually required to provide a detailed history of all anti-seizure medications they have tried, including dosages, duration of treatment, and reasons for discontinuation. This information helps researchers determine whether a participant truly has drug-resistant epilepsy and whether they meet the trial's specific inclusion criteria. In some cases, participants must be on a stable medication regimen for a certain period before enrolling.

Ongoing Monitoring During the Trial

Once enrolled in a clinical trial, participants undergo regular monitoring to track their seizures, medication side effects, and overall health. This often includes repeated EEGs, blood tests, and check-ins with the research team. Participants are usually asked to keep detailed seizure diaries and to report any new symptoms or concerns promptly.

The rigorous diagnostic and monitoring requirements in clinical trials help ensure participant safety and the accuracy of the study results. While the process may seem demanding, it also means that participants receive close medical attention and access to cutting-edge treatments that may not yet be available to the general public.

Prognosis and Survival Rate

Prognosis

The outlook for people with epilepsy varies widely depending on several factors, including the type of epilepsy, the underlying cause, the age at which seizures begin, and how well seizures respond to treatment. Many people with epilepsy can lead full and active lives, especially when their seizures are well controlled.

It is estimated that up to 70% of people living with epilepsy could become seizure-free if they are properly diagnosed and treated with appropriate medications. For these individuals, treatment with anti-seizure medications can effectively control their seizures, allowing them to work, drive, and participate in most activities without significant restrictions. Some people who remain seizure-free for two years or more may even be able to gradually reduce or stop their medications under medical supervision.

However, about 30% of people with epilepsy continue to have seizures despite trying multiple medications. This is known as drug-resistant or refractory epilepsy. For these individuals, other treatment options such as surgery, devices like the RNS System or vagus nerve stimulation, or special diets like the ketogenic diet may help reduce seizure frequency or severity.

Factors that can affect prognosis include the presence of other neurological conditions, the cause of the epilepsy (such as brain injury, stroke, or genetic factors), and the age at which seizures begin. Children who develop epilepsy sometimes outgrow their seizures as they mature, particularly with certain types of childhood epilepsy. On the other hand, epilepsy that begins in older adults is often related to other conditions like stroke or dementia, which can complicate management.

Survival Rate

While most people with epilepsy have a normal lifespan, there are some increased risks associated with the condition. The risk of premature death in people with epilepsy is up to three times higher than in the general population. This increased risk is largely related to accidents or injuries that can occur during seizures, such as falls, drowning, or burns. Severe, prolonged seizures can also be life-threatening, particularly if they lead to a condition called status epilepticus, where a seizure lasts longer than five minutes or multiple seizures occur without recovery in between.

There is also a rare but serious condition called Sudden Unexpected Death in Epilepsy, or SUDEP, which accounts for some deaths in people with epilepsy. SUDEP is more common in individuals with frequent, uncontrolled seizures, particularly tonic-clonic seizures. While the exact cause of SUDEP is not fully understood, it is believed to involve disruptions in breathing, heart rhythm, or brain function during or after a seizure. Good seizure control is the most important factor in reducing the risk of SUDEP.

It is important to note that with proper treatment and management, the vast majority of people with epilepsy can live long, healthy, and fulfilling lives. Working closely with your healthcare team, taking medications as prescribed, and following safety precautions can significantly improve outcomes and reduce risks.

Did you know?

  1. Epilepsy is one of the world's oldest recognized medical conditions, with written records dating back to 4000 BCE—yet diagnostic tools like EEG were only invented in the 1920s[2].
  2. The brain continuously generates tiny electrical impulses, and during an EEG, these signals are so small that they measure only a few millionths of a volt—yet they can reveal critical information about seizure activity[8].
  3. Approximately 70% of healthcare decisions are influenced by diagnostic test results, yet only 3-5% of healthcare budgets are typically allocated to diagnostic services[29].

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.